# Insulin medicines: Interventions

Source page: https://www.materialinsights.org/products/p_insulin_medicines/prod-interventions/

#### Interventions

Changes that would cut emissions or material use, by lever and life stage, with effect per unit, readiness, adoption, evidence and who acts

| Lever | Life stage | Change | Effect per unit | Readiness | Adoption | Who acts | Source |
|---|---|---|---|---|---|---|---|
| Efficiency | Use | Switch from once-daily to once-weekly basal insulin | Pens per patient per year fall from 22 to 5; for a sample of 100,000 patients the study reports 37 tons less plastic waste and 1.7 kilotons less carbon emissions a year, about 17 kg per patient per year (calculated within this one source) ^[14] | Deployed (a weekly insulin is on sale in India in 2026 ^[10]) | Not stated; modelled for France by authors from Novo Nordisk and the consultancy Putnam | Prescribers, makers, health systems | ^[14]^[10] |
| Design | Components design | Use a durable (reusable) pen with replaceable cartridges instead of a disposable pen | Carbon data Novo Nordisk gave an NHS team, for 1,000 people using pens for a year: 15,000 kg CO2e with disposable pens and 8,200 kg CO2e with durable pens lasting 5 years, so about 15 kg per person a year with disposable pens (calculated); the team did not know what the footprint included ^[15] | Deployed | Not stated | Makers, prescribers | ^[15] |
| Circularity | End of life | Take back used pens for recycling | Novo Nordisk says about 200,000 pens were returned in the UK by August 2023 and about two tonnes of plastic waste saved ^[16]; an NHS team calculates 0.0041347 kg CO2e per pen via PenCycle against 0.004128 in the black bag, so almost no carbon difference ^[15] | Deployed (national roll-out in October 2022) | About 3,700 UK community pharmacies registered, the company says | Makers, pharmacies, patients | ^[16]^[15] |
| Design | Supply chain | Allow insulin to be kept warm for longer before opening | WHO-prequalified human insulins by Novo Nordisk may be kept at up to 30 degrees C for four weeks before opening, which WHO says should ease use where refrigeration is limited ^[7] | Deployed | The four prequalified products | Makers, regulators | ^[7] |

as of 2026-11-13

#### Sources

1. [First human insulins prequalified](https://extranet.who.int/pqweb/news/first-human-insulins-prequalified) World Health Organization, Prequalification of Medical Products, 2022, news item of 28 September 2022
2. [India 2030: Who Supplies the Next 10 Million?](https://www.biospectrumindia.com/features/18/28731/india-2030-who-supplies-the-next-10-million.html) BioSpectrum India (Ankit Kankar), 2026, article of 1 November 2026
3. [Environmental Impact of Switching from Daily to Weekly Basal Insulin Administration in France](https://www.ispor.org/heor-resources/presentations-database/presentation/euro2024-4014/145501) ISPOR Europe 2024 abstract EE212 (Bellier L, Antier C, Soggiu M, Virely N, Laporte L, Sivignon M, Kind B; affiliations Putnam, Paris, and Novo Nordisk, Paris), Value in Health 27(12) S2, 2024
4. [Improving the environmental impact of patients with diabetes and on insulin.](https://production.networks.sustainablehealthcare.org.uk/sites/default/files/2023-10/Diabetes%20-%20SusQI%20Project%20Report_0.pdf) Centre for Sustainable Healthcare SusQI project report template, completed by a community diabetes team in North Warwickshire, 2023, Aim 1 (Novo Nordisk carbon data for pens) and Aim 2 (PenCycle, the team's own per-pen calculation); date of report 14 July 2023
5. [Patients return 200,000 injection pens through recycling scheme](https://pharmaceutical-journal.com/article/news/patients-return-200000-injection-pens-through-recycling-scheme) The Pharmaceutical Journal (David Lipanovic), 2023, article of 15 August 2023

## Other sections

- [Summary](https://www.materialinsights.org/products/p_insulin_medicines/index.md)
- [Working](https://www.materialinsights.org/products/p_insulin_medicines/prod-working/index.md)
- [Bill of materials](https://www.materialinsights.org/products/p_insulin_medicines/prod-bom/index.md)
- [Use case](https://www.materialinsights.org/products/p_insulin_medicines/prod-use/index.md)
- [Supply chain](https://www.materialinsights.org/products/p_insulin_medicines/prod-supply/index.md)
- [Footprint](https://www.materialinsights.org/products/p_insulin_medicines/prod-footprint/index.md)
- [Evolution](https://www.materialinsights.org/products/p_insulin_medicines/prod-evolution/index.md)
